Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

<p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks)...

Shranjeno v:

Bibliografske podrobnosti
Glavni avtor:	Abdullah A. Osman (15056323) (author)
Drugi avtorji:	Emre Arslan (15056326) (author), Mason Bartels (15056329) (author), Chieko Michikawa (15056332) (author), Antje Lindemann (15056335) (author), Katarzyna Tomczak (15056338) (author), Wangjie Yu (15056341) (author), Vlad Sandulache (15056344) (author), Wencai Ma (15056347) (author), Li Shen (14959241) (author), Jing Wang (14959256) (author), Anand K. Singh (15056350) (author), Mitchell J. Frederick (14959253) (author), Nakia D. Spencer (15056353) (author), Jeffery Kovacs (15056356) (author), Timothy Heffernan (15056359) (author), William F. Symmans (15056362) (author), Kunal Rai (15056365) (author), Jeffrey N. Myers (15026901) (author)
Izdano:	2025
Teme:	Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
od: Abdullah A. Osman (15056323)
Izdano: (2025)

Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
od: Abdullah A. Osman (15056323)
Izdano: (2025)

Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
od: Abdullah A. Osman (15056323)
Izdano: (2025)

Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
od: Abdullah A. Osman (15056323)
Izdano: (2025)

Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
od: Abdullah A. Osman (15056323)
Izdano: (2025)

Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer
od: Sankar Jagadeeshan (15112900)
Izdano: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
od: Xiaohong Hong (22681698)
Izdano: (2025)

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
od: Niklas Klümper (15048887)
Izdano: (2025)

Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
od: Niklas Klümper (15048887)
Izdano: (2025)

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
od: Hong Qiu (14963144)
Izdano: (2025)

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
od: Hong Qiu (14963144)
Izdano: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
od: Dipika R. Mohan (15011204)
Izdano: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
od: Jeffrey D. Mandell (14963909)
Izdano: (2025)

Table S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Izdano: (2025)

Table S2 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Izdano: (2025)

Table S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Izdano: (2025)

Table S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
od: Kosuke Toyoda (16698360)
Izdano: (2025)

Supplementary Data 1 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
od: Chen Chen (16799528)
Izdano: (2025)

Supplementary Data 3 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
od: Chen Chen (16799528)
Izdano: (2025)

Supplementary Data 4 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
od: Chen Chen (16799528)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Figure from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Supplementary Table from Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer
od: Amrita M. Nargund (14956685)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3rn5f00laif4a60t95v669jiti